Intensive Chemotherapy in Patients Aged 70 Years or Older Newly Diagnosed With Acute Myeloid Leukemia

Acute myeloid leukemia (AML) represents a major therapeutic challenge in the elderly. Because of the high treatment-related mortality and poor overall outcomes of remission induction therapy, many older patients are not considered candidates for intensive chemotherapy. The current study evaluated pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Kelly, Gillespie-Twardy, Amanda L., Agha, Mounzer, Raptis, Anastasios, Hou, Jing-Zhou, Farah, Rafic, Redner, Robert L., Im, Annie, Duggal, Shrina, Ding, Fei, Lin, Yan, Boyiadzis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838424/
https://www.ncbi.nlm.nih.gov/pubmed/25706395
http://dx.doi.org/10.3727/096504014X14146137738547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838424/
https://www.ncbi.nlm.nih.gov/pubmed/25706395
http://dx.doi.org/10.3727/096504014X14146137738547

Ejemplares similares